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Summary and General Discussion
Introduction
Adverse reactions to cow's milk, indicated as cow's milk protein allergy or intoler-
ance (CMPA/CMPI), are one of the most common adverse reactions to foods in in-
fancy and early childhood with an incidence ranging from2To Io 5%o, when strict
diagnostic criteria are used.'-' ' The diagnosis CMPA/CMPI has to be based on the
clinical response to cow's milk.n-n Following dietary elimination of cow's milk pro-
tein, the prognosis of CMPA/CMPI is good with a remission rate of 90%o at three
years of age.' Only a few longterm prospective follow-up studies have focused on
the prognosis of CMPA/CMPI with respect o the development of additional aller-
gic disorders later in childhood. These studies demonstrate that the development
of asthma, atopic dermatitis, allergic rhinitis/conjunctivitis, and food intolerance
Iater in childhood is substantial.rr3It has been hypothesized that early dietary in-
tervention and environmental measures may influence the development of subse-
quent allergic symptoms. Primairy preventive effects of dietary intervention dur-
ing lactation and in the neonatal period on the development of allergic symptoms
have been demonstrated in high risk infants, i.e. infants with at least one parent or
sibling with an atopic disorder.ro-2s It has been hypothesized that secondary pre-
vention, including early dietary intervention with a protein hydrolysate based for-
mula, could modulate the "atopic march" in infants with CMPA/CMPI. However,
it is stii l a matter of debate whether there is a preventive effect of dietary interven-
tion on the development of additional allergic disorders in children with
CMPA/CMPI in infancy, due to the absence of controlled studies. Moreover, in
the few longterm follow-up studies which focused on the prognosis of
CMPA/CMPI with respect to the development of subsequent allergic disorders,
the age at which the diagnose was made, and consequently the age at which di-
etary intervention was started, varied widely. Furthermore, it is not clear, due to
the character of these uncontrolled studies, whether early treated CMPA/CMPI
may be a risk factor for the development of allergic symptoms. Additionally, the
outcome of allergy in children with CMPA/CMPI in infancy is not clear due to a
lack of uniform diagnostic definitions, and standardized methods in assessing the
presence or severity ofan allergic disorder in this young age group.
The studies described in this thesis aimed to fil l in these hiatuses in the
field of CMPA/CMPL In this thesis the first controlled prospective follow-up
study on the development of allergic disorders in children with CMPA/CMPI in
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infancy is presented. In this follow-up study through a mean age of 7 years all in-
fants with CMPA/CMPI were diagnosed by a strict well defined elimination and
provocation procedure during the first three months of life. Consequently, this is
the first follow-up study in which all infants with CMPA/CMPI received dietary
intervention with an extensively hydrolysed whey protein based formula starting
before the fourth month of age.
Summary of the studies
Chapter one contains a concise review of the literature including, definitions, di-
agnostic criteria, clinical manifestations, treatment, aetiology, pathogenesis, and
prognosis of CMPA/CMPI. Furthermore, the aims of the studies are described.
The aim of this thesis was to investigate, in a prospective follow-up study through
age 7 years, the subsequent development of allergic disorders in children with
CMPA/CMPI diagnosed by elimination and challenge of cow's milk protein dur-
ing the first three months of life, and treated with an extensive protein hydrolysate
based formula. Furthermore, to investigate the clinical outcome of allergy in chil-
dren in whom the diagnosis CMPA/CMPI was suspected but could be rejected on
the basrs of the same elimination and challenge procedure during the first three
months of life. Moreover, to determine risk factors for the development of addi-
tional allergic disorders later in childhood. Additionally, to develop and study al-
ternative methods to assess bronchial hyperresponsiveness in children, in order
to apply these methods in the young children participating in the follow-up study.
Furthermore, to critically review and study some of the available, and in research
most used atopic dermatitis severity scoring systems in order to give information
about the advantages and disadvantages ofthese scoring systems, and therefore,
to contribute to a more informed choice in which severity scoring system to use in
research concerning atopic dermatitis.
In Chapter two (A) we presented a study in which we determined whether a
change in lung sounds in asthmatic children corresponded with a 20Vo fall in
forced expiratory volume in one second (FEV') after methacholine challenge, and
whether the occurrence of wheeze was the most important change. This study
showed that changes in lung sounds correspond well with a20Vo fall in FEV' after
methacholine challenge. In contrast with previous studies in which wheeze was
the indicator of bronchial responsiveness, we found wheeze by itself to be a poor
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indicator for assessing bronchial reponsiveness. Cough, increase in respiratory
rate, and prolonged expiration were more frequently found.
In Chapter two (B), we investigated the agreement between the total cumulative
histamine dose causing a fall in FEV, of 20%o or more and the detection of a
change in lung sounds after two bronchial challenges at different occasions in
asthmatic children. In this study we found good agreement between the total cu-
mulative histamine dose causing a fall in FEV1 of 207o or more and the detection
ofa change in lung sounds after two bronchial challenges at different occasions.
The observation that not only the appearance of wheeze was an indicator of
bronchial reponsiveness, but also the appearance of cough, increase in respirato-
ry rate, and a prolonged expiration, was in accordance with the first study pre-
sented in this chapter. We conclude that for routine clinical assessment of
bronchial responsiveness in asthmatic children changes in lung sounds can be
used provided that attention is paid, not only to the occurrence ofwheeze, but also
to cough, increase in respiratory rate, and a prolonged expiration.
In Chapter three a study is presented in which we investigated whether an in-
crease in transcutaneous measured electromyographic (EMG) activity of the di-
aphragm and intercostal muscles corresponds with the concentration of hista-
mine that induces a20Vo fall in the FEV' in asthmatic children. We found that an
increase of the transcutaneous diaphragmatic and intercostal EMG activity ratio
(EMCAR) corresponds closely to a histamine induced 20vo fall in FEVr in asth-
matic children. In all children reaching a207o fall in FEV, after histamine chal-
lenge, an increase in the EMG activity of the diaphragm and intercostal muscles
was observed. In these children, no increase in diaphragmatic and/or intercostal
EMGAR was found at the dose step before the PCz,,-histamine was reached. This
study is the first study which investigated the use of diaphragmatic and inter-
costal EMC after histamine- or methacholine-induced bronchoconstriction i  the
assessment of bronchial responsiveness in humans. We conclude that the assess-
ment of bronchial responsiveness by measuring the transcutaneous diaphragmat-
ic and intercostal muscle activity during the inhalation challenge could be a
method for younger children who are not able to perform spirometry reliably.
In Chapter four we presented an overview of available atopic dermatitis severity
scoring systems in which we focused on the usefulness and validity of the differ-
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ent scoring systems. A number of scoring systems are being used for clinical and
research purposes. However, assessing the severity of atopic dermatitis in a re-
producible manner by this scoring systems is difficult. Even after training, and by
dermatologically experienced physicians, it is demonstrated that a considerable
interobserver variation exists in assessing the severity of atopic dermatitis by
most scoring systems. We conclude that the choice for a certain scoring system
needs to depend on the purpose of its use, the feasability, the accuracy, the sensi-
tivity, and whether or not the scoring system has been validated. A scoring system
with a minimum intraobserver and interobserver variation has the preference. We
recommend that a simple, rapid, and reprodur: ible scoring system wi l l  suff ice,
when only a rough estimation of the severity of atopic dermatitis, as in longterm
follow-up studies, is needed. A more elaborating system is recommended if sub-
tle modifications in the severity of atopic dermatitis needs to be detected. Howev-
er, we warn that one should be aware of significant interobserver variation in the
assessment of isolated intensity items, the extent, as well as in subjective patient
symptoms. Furthermore, we advise to use a scoring system in which the interob-
server variation is minimized, and this can be accomplished by a system in which
the intensity items, the extent, and the subjective symptoms are scored separate-
Iy. For clinical trials it is necessary to use a scoring system, which is prirnarily de-
signed for this purpose. It is recommended for research purposes to have the
atopic dermatitis severity scores assessed by a single observer, in order to avoid
interobserver variation.
Furthermore, a study is presented in this chapter in which we compared
three atopic dermatitis severity scoring systems. In this study we investigated
agreement between observers in the assessmenl of the overall severity of atopic
dermatitis, and interobserver variation in the assessment of severity of atopic der-
matitis for each scoring item seperately, with the Simple Scoring System (SSS),
the Scoring Atopic Dermatitis Index SCORAD), and the Basic Clinical Scoring
System (BCSS). Moreover, we investigated agreement between these three scor-
ing systems in the assessment of the overall severity of atopic dermatitis. We
found good agreement between observers assessing the overall severity of atopic
dermatitis in the lower and higher scoring rates by the SSS and the SCORAD, and
excellent agreement by the BCSS. Furthermore, we found significant interobserv-
er variation on the isolated intensity items scales, excoriations, edema./papula-
tion, and erythema. Moreover, we found poor agreement between the three scor-
ing systems in assessing the overall severity of atopic dermatitis, indicating that
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the SSS, the SCORAD, and the BCSS cannot be used interchangeably to assess
the overall severity of atopic dermatitis. We conlcude that the BCSS is an excel-
lent and simple score to detect the development of atopic dermatitis, whereas the
SSS, and the SCORAD are suitable to follow-up the severity of atopic dermatitis.
A single observer is essential for studies assessing the modifications in the sever-
ity of AD, because we demonstrated significant interobservariations in scoring
intensity items. Moreover, atopic dermatitis severity scoring systems should not
be used interchangeablY.
In Chapter five and Chapter six we presented the results of the prospective fol-
low-up study on the development of allergic disorders in children with and with-
out cow's milk protein allergy or intolerance (CMPA/CMPI)' In this follow-up
study we investigated the prevalences of allergic disorders, total IgE, specific IgE
against inhalant and food allergens, bronchial hyperresponsiveness (BHR), and
risk factors for the development of allergic disorders in children with
CMPA/CMPI diagnosed by elimination and provocation test during the first three
months of life, and treated with an extensive protein hydrolysate based formula'
Moreover, these parameters were investigated in children in whom the diagnosis
was suspected, but could be rejected on the basis of the same standardized elimi-
nation and provocation procedure during the first three months of life (non-CM-
PA). In chapter five cross-sectional data are presented at a mean age at follow-up
of 4.9 years. In chapter six cross-sectional as well as longitudinal data are pre-
sented from a mean age of 3.8 years through a mean age of 6'8 years. We found
that the prevalence of allergic disorders at a mean age of 4.9 years as well as at a
mean age of 6.8 years was substantial. However, no statistical significant differ-
ence in prevalences of any of the allergic disorders was found between these two
age periods. At a mean age of 6.8 years, at final follow-up, 3l7o of the children
with CMPA/CMPI in infancy had developed asthma, 377o atopic dermatitis, l77o
allergic rhinitis, LgVo allergic conjunctivitis, and 3l7o food intolerance. Howev-
er, no significant statistical differences were found at a mean age of 4.9 years' nor
at a mean of 6.8 years, in the prevalences of allergic disorders, total serum IgE,
specific IgE against food and inhalant allergens, BHR, and severity of atopic der-
matitis between children with and without CMPA/CMPI. No significant statistical
difference was found in the course of the reported prevalences of asthma, atopic
dermatitis, and allergic conjunctivtis between children with and without CM-
PA/CMPI during the follow-up period from a mean age of 3.8 years to a mean age
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of 6.8 years. Food intolerance was significantly more reported, and allergic rhini-
tis was significantly less reported in the CMPA/CMPI than in the non-
CMPA/CMPI group at a mean age of 3.8 years. However, the point prevalences of
allergic rhinitis increased significantly in the CMPA/CMPI group from a mean
age of 3.8 to 6.8 years. In contrast, the point prevalences of allergic rhinitis in the
non-CMPA/CMPI group decreased significantly from a mean age of 3.8 to 6.8
years. In chapter five we showed by cross-sectional logistic regression analysis
that CMPA/CMPI is not a significant risk factor for the development of any of the
allergic disorders at a mean age of 4.9 years. Other well known factors, as atopy
among first degree relatives, wheeze during the first year of life, and passing
through a serious lower respiratory tract infection before the age of 4.9 years,
were significant risk factors for allergic disorders at a mean age of 4.9 years. Fur-
thermore, total serum IgE, and sensitization to inhalant and food allergens were
significantly associated with allergic disorders at a mean age of 4.9 years. Per-
forming longitudinal data analysis over the total follow-up period from a mean age
of 3.8 years to a mean age of 6.8 years, as described in chapter six, we could con-
firm the results as found at a mean age of 4.9 years. Again, CMPA/CMPI was not a
significant risk factor for asthma, atopic dermatitis, allergic rhinitis, allergic con-
junctivitis, and food intolerance. Atopy among first degree relatives, wheeze dur-
ing the first year oflife, a serious lower respiratory tract infection, sensitization to
food and inhalant allergens, and bronchial hyperresponsiveness appeared to be
independent significant risk factors for the presence of allergic disorders in our
study populat ion.
Ceneral discussion
Due to an worlwide increase in the prevalence, and rnorbidity of allergic disor-
ders there is a need to identify allergy prevention strategies.2:r'tu Several studies
have been performed in "high risk for atopy infants", and have focused on the pri-
mairy prevention of allergic disorders, including food allergen avoidance during
lactation, and in the neonatal period.rn'"'27-2e Extensive, and partial hydrolysed
protein based formulas have been proven to be effective in the primary preven-
tion ofallergic disorders in high risk infants, particularly in the prevention offood
intolerance, including CMPA/CMPI, atopic dermatitis, and asthma.t4't7'20'22'2s'26'28'
't" '" However, some of these studies have demonstrated that dietary intervention
during infancy did not prevent the development of asthma and allergic rhinitis
later in childhood.'n 20'28'2e Only one studv investieated the combination of food al-
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